- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Chemclin Diagnostics Co Ltd (688468)
The Chemclin Diagnostics share price today is 6.69, view SS 688468 stock exchange data. Track the latest Chemclin Diagnostics share price with real-time updates on 688468 stock performance including market cap, day range, 52-week range and dividend yield. Access 688468 charts, earnings dates and analyst estimates to support your investment decisions.
Shanghai
Currency in CNY
6.69
+0.09(+1.36%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.48
6.75
52 wk Range
5.50
8.55
688468 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.486.75
52 wk Range
5.508.55
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
688468 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Earnings
Latest Release
27-08-2026
EPS / Forecast
0.02 / --
Revenue / Forecast
81.12M / --
Compare 688468 to Peers and Sector
Metrics to compare | 688468 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship688468PeersSector | |
|---|---|---|---|---|
P/E Ratio | 75.2x | 23.2x | −0.3x | |
PEG Ratio | −1.44 | −1.03 | 0.00 | |
Price/Book | 1.9x | 2.2x | 2.6x | |
Price / LTM Sales | 8.2x | 6.0x | 3.0x | |
Upside (Analyst Target) | - | 29.4% | 61.2% | |
Fair Value Upside | Unlock | 22.6% | 7.2% | Unlock |
Chemclin Diagnostics Co., Ltd. engages in the research, development, production, and sale of clinical immuno chemiluminescence diagnostic reagents and instruments in China. The company offers the LiCA series of diagnostic reagents, which is based on photo-induced chemiluminescence; the Chemclin series of diagnostic reagents and instruments, which is based on enzyme-catalyzed chemiluminescence; and routine clinical chemistry diagnostic reagents. Its products are used for the detection of biomarkers for infectious diseases, such as hepatitis B, hepatitis C, HIV, syphilis, hepatitis A, and hepatitis E, etc., as well as of tumor markers, thyroid hormones, reproductive endocrine hormones, cardiac markers, and inflammation. The company serves large and medium-sized hospitals, health check-up centers, emergency rooms, clinical laboratories, emergency departments, chest pain centers, and community centers. Chemclin Diagnostics Co., Ltd. was founded in 2005 and is headquartered in Beijing, China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Chemclin Diagnostics (688468) Share Price Today?
The Chemclin Diagnostics share price today is 6.69.
What is the current Chemclin Diagnostics (688468) share price and day range?
As of 11-10-2026, the Chemclin Diagnostics share price is 6.69, with a previous close of 6.69. The share price has ranged from 6.48 to 6.75 today, while the 52-week range spans from 5.50 to 8.55.
What Is the Chemclin Diagnostics Market Cap?
As of today, Chemclin Diagnostics market cap is 2.64B.
What Is Chemclin Diagnostics's Earnings Per Share (TTM)?
The Chemclin Diagnostics EPS (TTM) is 0.09.
From a Technical Analysis Perspective, Is 688468 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Chemclin Diagnostics Trade On?
Chemclin Diagnostics is listed and trades on the Shanghai Stock Exchange.
What Is the Stock Symbol for Chemclin Diagnostics?
The stock symbol for Chemclin Diagnostics is "688468."
How Many Times Has Chemclin Diagnostics Stock Split?
Chemclin Diagnostics has split 0 times.
How Many Employees Does Chemclin Diagnostics Have?
Chemclin Diagnostics has 573 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.